1. Academic Validation
  2. Processing and activation of pro-interleukin-16 by caspase-3

Processing and activation of pro-interleukin-16 by caspase-3

  • J Biol Chem. 1998 Jan 9;273(2):1144-9. doi: 10.1074/jbc.273.2.1144.
Y Zhang 1 D M Center D M Wu W W Cruikshank J Yuan D W Andrews H Kornfeld
Affiliations

Affiliation

  • 1 Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA. [email protected]
Abstract

Interleukin-16, a proinflammatory cytokine produced in CD8(+) lymphocytes, is synthesized as a precursor protein (pro-IL-16). It is postulated that the C-terminal region of pro-IL-16 is cleaved, releasing bioactive IL-16. To characterize IL-16 cleavage, we transfected COS cells with a cDNA encoding a approximately 50-kDa form of pro-IL-16. Transfected COS cells released a approximately 20-kDa IL-16 cleavage product shown to consist of the 121 C-terminal residues of pro-IL-16 by immunoblotting and amino acid sequencing. Cleaved IL-16, but not pro-IL-16, exhibited lymphocyte chemoattractant activity. A C-terminal approximately 20-kDa IL-16 polypeptide was also released when pro-IL-16 was treated with concanavalin A-stimulated CD8(+) lymphocyte lysate. Cleavage occurred after an Asp, suggesting involvement of a Caspase (interleukin-1beta-converting Enzyme/CED-3) family protease. Using recombinant caspases and granzyme B, we determined that pro-IL-16 cleavage is mediated only by Caspase-3. Relevance to pro-IL-16 processing in primary lymphocytes was supported by identifying the p20 subunit of activated Caspase-3 in stimulated CD8(+) lymphocytes and by inhibition of CD8(+) lymphocyte lysate-mediated cleavage with Ac-DEVD-CHO. Pro-IL-16 is a substrate for Caspase-3, and cleavage by this Enzyme releases biologically active IL-16 from its inactive precursor.

Figures
Products